Search clinical trials for: Extended Release Buprenorphine

Total 6610 results

GlaxoSmithKline
Quotient Clinical

Completed

A Study to Compare the Pharmacokinetics (PK) of GSK2982772 Following Administration of Different Modified Release (MR) Formulations in Capsule and MR Tablet Formulations Relative to an Immediate Release (IR) Tablet Formulation and to Check the PK of MR Formulation in Capsule Following Repeat Doses

Autoimmune Diseases

United Kingdom
GlaxoSmithKline
Quotient Sciences

Completed

A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772

Autoimmune Diseases

United Kingdom
Chinese University of Hong Kong

Completed

Study of Open and Percutaneous Release of Acquired Trigger Thumb

Trigger Thumb

Hong Kong
Indivior Inc.

Completed

Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population

Opioid Dependence

United States
Trisha Wise-Draper
American Cancer Society, Inc.

Active, not recruiting

Combining Pembrolizumab and Metformin in Metastatic Head and Neck Cancer Patients

Head and Neck Squamous Cell Carcinoma

United States
University of Colorado, Denver

Terminated

Immunosuppressant Medication Dosed Daily After Kidney Transplant

Medication Adherence | Kidney Transplant Rejection

United States
University of Colorado, Denver

Completed

Intrathecal Morphine Versus Epidural Extended Release Morphine for Pediatric Patients Undergoing Spinal Fusion

Scoliosis | Pain Management | Spinal Fusion

United States
Boehringer Ingelheim

Completed

Influence of Pramipexole Extended Release on Medication Adherence in Parkinson´s Disease

Parkinson Disease
Samsung Medical Center
Pfizer

Completed

Assessment of Patient-reported Goal Attainment in the Treatment of Female Overactive Bladder

Overactive Bladder

Korea, Republic of
NYU Langone Health
Alkermes, Inc.

Completed

Extended-release Naltrexone for Alcohol Dependence in Primary Care

Alcohol Dependence

United States
Daniel A. Siniawski
Merck Sharp & Dohme LLC

Terminated

Lipid Efficacy of the Extended Release Niacin/Laropiprant Combination in Patients With Cardiovascular Disease

Coronary Artery Disease | Dyslipidemias

Argentina
University of Minnesota

Completed

Enhancing Weight Loss Maintenance With GLP-1RA (BYDUREON™) in Adolescents With Severe Obesity

Severe Obesity

United States
Yale University
National Institute on Drug Abuse (NIDA); Baystate Medical Center

Completed

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations (NewHope)

HIV | Opioid Dependence | AIDS | Drug Dependence

United States
Universitätsklinikum Hamburg-Eppendorf
Olympus Deutschland GmbH

Completed

How Effective Can a Simulator-Based Training Course For Beginners In Endoscopy Be Made? (EFFEKTRA)

Physicians Gastroscopy Training

Germany
University of Oregon

Completed

Sleep and Girls' Emotions Study (SAGE)

Depression

United States
Xinrui Zhu，MD

Not yet recruiting

Extended Pancreatic Transection Versus Conventional Pancreatic Transection During Laparoscopic Pancreaticoduodenectomy

Laparoscopic Pancreaticoduodenectomy
Chung-Ang University
National Research Foundation of Korea

Completed

Effects of Daily Eating Duration on Health

Nutritional and Metabolic Diseases | Body Weight Maintenance

Korea, Republic of
Maastricht University Medical Center
RWTH Aachen University

Unknown

Atrial Fibrillation Ablation Registry (AFAB)

Atrial Fibrillation (Paroxysmal) | Atrial Fibrillation Recurrent | Atrial Fibrillation Common Gene Variants

Netherlands
Meshalkin Research Institute of Pathology of Circulation

Unknown

Comparisonof Extended Myoectomy and Myoectomy by Morrow in Patients With Hypertrophic Obstructive Cardiomyopathy (HOCM)

Hypertrophic Obstructive Cardiomyopathy

Russian Federation
Yonsei University

Unknown

Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block

Herpes Zoster | CRPS

Korea, Republic of
Riphah International University

Recruiting

Effects of Myofascial Release in Cerebral Palsy Children

Cerebral Palsy

Pakistan
Riphah International University

Completed

Positional Release Technique in Patients With Unilateral Subacute Trapezitis

Cervical Spine Disease

Pakistan
Philips Clinical & Medical Affairs Global

Recruiting

Arrhythmia Identification in Syncope Patients: ePatch® Versus 24h Holter

Syncope | Arrythmia

France, Germany
Northwestern University
National Center for Complementary and Integrative Health (NCCIH)

Completed

Awareness and Self-Compassion Enhancing Narcolepsy Treatment (ASCENT)

Narcolepsy | Narcolepsy Without Cataplexy | Narcolepsy With Cataplexy

United States
Imperial College London

Unknown

Effects of Extended Haemodialysis Treatment Duration in Patients With End-stage Renal Disease

End Stage Renal Disease

United Kingdom
UConn Health

Completed

Length of Post Operative Dressing After Carpal Tunnel Release

Carpal Tunnel Syndrome

United States
Boehringer Ingelheim

Completed

Relative Bioavailability of Different Oral Viramune Extended Release Formulations Compared to Viramune® Oral Suspension in Healthy Male Volunteers

Healthy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating the Pharmacokinetics of Venlafaxine Extended-Release (ER) and Desvenlafaxine Succinate Sustained-Release (DVS SR) 50 mg in Healthy Subjects

Healthy

United States
University of Zurich

Terminated

Effects of Buprenorphine on Ulnar Nerve Motor Block

Healthy Volunteers

Switzerland
Ohio State University

Withdrawn

Long Acting Subcutaneous vs Short Acting Sublingual Buprenorphine in Pregnant and Lactating Women

Opioid Use Disorder

United States
Purdue Pharma LP

Withdrawn

Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe Pain

Other Acute Postoperative Pain | Prolonged Endotracheal Intubation
Mundipharma (China) Pharmaceutical Co. Ltd

Completed

Norspan Transdermal Patches Study in Osteoarthritis Patients

Osteoarthritis Disorders

China
Pfizer

Completed

A Study To Evaluate Different Formulations Of PF-06865571 In Healthy Subjects

Healthy

Belgium
Cedars-Sinai Medical Center
Astellas Pharma Inc

Completed

Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients

End Stage Renal Disease

United States
Shire

Completed

Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis

Colitis, Ulcerative

United States
NYU Langone Health
Alkermes, Inc.; New York City Department of Health and Mental Hygiene

Completed

Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail

Opiate Dependence

United States
Hannover Medical School

Completed

The High Density Lipoprotein and Endothelial Function, Niacin and Nitric Oxide Study (The High-Ennd Study)

Metabolic Syndrome

Germany
Dokuz Eylul University

Recruiting

Effects of Myofascial Release Technique on Mobility, Sensorimotor Function and Performance in Volleyball Players

Athletes | Volleyball

Turkey
Université de Sherbrooke

Completed

Effects of a Myofascial Technique on Biomechanical Properties of the Lumbar Myofascia of Chronic Low Back Pain Adults

Chronic Low Back Pain

Canada
NYU Langone Health
Winthrop University Hospital

Withdrawn

Dose Clinical Trial of Guanfacine Extended Release for the Reduction of Aggression and Self-injuries Behavior Associated With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence (TACT2)

Cocaine Dependence

United States
Oregon Health and Science University
National Institute on Drug Abuse (NIDA)

Completed

Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study (CHOICES)

Opioid Use Disorder | Alcohol Use Disorder

Canada, United States
Merck KGaA, Darmstadt, Germany

Completed

Tolerability of Rebif® (Interferon-beta 1-A) Therapy in Korean Patients With Multiple Sclerosis

Multiple Sclerosis

Korea, Republic of
Maimonides Medical Center

Recruiting

Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome (PWS-GXR)

Aggression | Behavioral Symptoms | Pathologic Processes | Nervous System Diseases | Obesity | Neurologic Manifestations | Neurobehavioral Manifestations | Congenital Abnormalities | Overnutrition | Nutrition Disorders | Genetic Diseases, Inborn | Intellectual Disability | Self-Injurious Behavior | Abnormalities, Multiple and other conditions

United States
Walter Reed National Military Medical Center

Completed

Local Anesthetics on Postsurgical Analgesia Following Posterior Colporrhaphy

Postoperative Pain

United States
Shire

Completed

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

Attention-deficit/Hyperactivity Disorder

Spain, Belgium, United States, Netherlands, United Kingdom, Italy, Germany, Canada, France, Sweden
Jacobus Pharmaceutical

Terminated

High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease in Children

Crohn's Disease

United States
Rhode Island Hospital
National Institute on Drug Abuse (NIDA); Alkermes, Inc.

Completed

Pre-Release VIVITROL for Opioid Dependent Inmates

Substance-Related Disorders

United States
Chemi S.p.A.

Completed

Extended-release of Octreotide (LF-PB) for the Treatment of Lymphorrhea

Lymphorrhea

Italy
The University of Texas Health Science Center at...
Shire

Completed

Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity

United States

Search clinical trials for: Extended Release Buprenorphine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations